Download PDF
Thromb Haemost 1981; 46(03): 669
DOI: 10.1055/s-0038-1653447
Letter to the Editor
Schattauer GmbH Stuttgart

Bidimensional Immunoelectrophoresis Abnormal Migration of Serum Antithrombin III in Coumarin-Treated Patients

Antonio Girolami
Institute of Semeiotica Medica, University of Padua Medical School, Padua, Italy
,
Giovanni M Patrassi
Institute of Semeiotica Medica, University of Padua Medical School, Padua, Italy
,
Giovanna Cappellato
Institute of Semeiotica Medica, University of Padua Medical School, Padua, Italy
,
Vittorio Pengo
Institute of Semeiotica Medica, University of Padua Medical School, Padua, Italy
› Author Affiliations
Further Information

Publication History

Received 27 April 1981

Accepted 09 August 1981

Publication Date:
05 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Kaula Evon, Kaula KN von. Antithrombin III and disease. Am J Clin Path 1967; 48: 69-80
    CrossrefPubMedGoogle Scholar
  • 2 Marciniak E, Farley CH, De Simone PhA. Familial thrombosis due to antithrombin III deficiency. Blood 1974; 43: 219-231
    PubMedGoogle Scholar
  • 3 Bull H, Mackie I, Brozovic M, Woodings D. Antithrombin III in patients on long-term oral anticoagulants. J Clin Pathol 1980; 33: 1202-1205
    CrossrefPubMedGoogle Scholar
  • 4 Girolami A, Pengo V, Patrassi GM, Cappellato G, Vianello C, Cartei L. Antithrombin III Padua: a “new” congenital antithrombin III abnormality with normal or near normal activity, normal antigen, abnormal migration and no thrombotic disease (in preparation).
    PubMedGoogle Scholar